Project: Scalable CAR-T cell therapy for available and affordable treatment of multiple myeloma (MM)

Acronym SCALE-CAR (Reference Number: 114700)
Duration 01/03/2021 - 01/03/2024
Project Topic CAR-T cell therapy has shown breakthrough clinical results with complete and durable tumor remissions. However, application is hampered due to the manual and complex manufacturing process. Current manufacturing capacity is not even sufficient for the first orphan indications and CAR-T costs >300,000 EUR/treatment. The SCALE-CAR consortium will deliver a disruptive automated CAR-T treatment that can be scaled to reach tens of thousands of MM patients against affordable costs.
Network Eurostars 2
Call Eurostars Cut–off 14

Project partner

Number Name Role Country
1 Antwerp University Hospital / Universitair Ziekenhuis Antwerpen (UZA) Partner Belgium
2 Cellpoint B.V. (CP) Coordinator Netherlands
3 Oxford Genetics Ltd. (OxG) Partner United Kingdom